25 Participants Needed

Brain Stimulation for ADHD

BC
Overseen ByBrian C Kavanaugh, PsyD ABPP
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 2 JurisdictionsThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

This trial tests if a device that sends small electrical pulses to the brain can help teenagers with ADHD improve their memory and attention. The treatment targets a specific brain area to make brain waves work better together.

Will I have to stop taking my current medications?

You can continue your current ADHD treatments, but you cannot make any changes to them during the study. If you need to change your treatment, it might lead to leaving the study.

What data supports the effectiveness of the treatment Intermittent Theta Burst Stimulation for ADHD?

Research shows that Intermittent Theta Burst Stimulation (iTBS) has shown promise in treating depression by targeting brain areas involved in mood regulation. While this is not directly about ADHD, it suggests that iTBS can influence brain activity, which might be beneficial for ADHD symptoms.12345

Is theta burst stimulation safe for humans?

Theta burst stimulation (TBS), including intermittent theta burst stimulation (iTBS), has been studied for safety in both adults and children. While generally considered safe, some people may experience tolerability issues, such as discomfort during treatment.12678

How does the treatment Intermittent Theta Burst Stimulation (iTBS) for ADHD differ from other treatments?

Intermittent Theta Burst Stimulation (iTBS) is a unique treatment that uses magnetic pulses to stimulate the brain, specifically targeting the left dorsolateral prefrontal cortex, which is different from traditional medication-based treatments for ADHD. This method is non-invasive and has been shown to be effective in treating depression, suggesting potential benefits for ADHD as well.1891011

Eligibility Criteria

This trial is for teenagers aged 13-18 with ADHD, an IQ over 80, and specific working memory challenges. They must have a clinical diagnosis of ADHD confirmed by the NICHQ Vanderbilt Assessment Scales-Parent and be fluent in English. Participants can continue their current ADHD treatments but cannot change them during the study.

Inclusion Criteria

13-18 years
Your IQ (intelligence quotient) should be higher than 80.
Parent rating on BRIEF-2 Working Memory: Greater than 1.0 SD above normative mean
See 6 more

Exclusion Criteria

You have a pacemaker.
Contraindicated metal implants in the head, brain or spinal cord (excluding dental implants, braces or fillings)
Non-removable makeup or piercings
See 21 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive a two-week course of active and sham iTBS to the left DLPFC

4 weeks
10 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Open-label extension (optional)

Participants may opt into continuation of treatment with more iTBS sessions

10-20 days

Treatment Details

Interventions

  • Intermittent Theta Burst Stimulation to the Left Dorsolateral Prefrontal Cortex
Trial OverviewThe trial tests Intermittent Theta Burst Stimulation to the Left Dorsolateral Prefrontal Cortex on teens with ADHD. It aims to see if this non-invasive brain stimulation can improve symptoms by affecting brain activity related to attention and impulsivity.
Participant Groups
2Treatment groups
Active Control
Placebo Group
Group I: Active intermittent Theta Burst StimulationActive Control1 Intervention
Participants will complete 10 daily sessions of active iTBS to the left dorsolateral prefrontal cortex
Group II: Sham intermittent Theta Burst StimulationPlacebo Group1 Intervention
Participants will complete 10 daily sessions of sham iTBS to the left dorsolateral prefrontal cortex

Intermittent Theta Burst Stimulation to the Left Dorsolateral Prefrontal Cortex is already approved in United States, European Union for the following indications:

🇺🇸
Approved in United States as iTBS for:
  • Major Depressive Disorder (MDD)
  • Obsessive-Compulsive Disorder (OCD)
🇪🇺
Approved in European Union as iTBS for:
  • Major Depressive Disorder (MDD)
  • Obsessive-Compulsive Disorder (OCD)

Find a Clinic Near You

Who Is Running the Clinical Trial?

Bradley Hospital

Lead Sponsor

Trials
22
Recruited
1,900+

Findings from Research

In a randomized, double-blind trial involving 56 patients, intermittent theta burst stimulation (iTBS) over the dorsomedial prefrontal cortex showed a significant reduction in negative symptoms for patients with depression, but not for those with schizophrenia.
The treatment was generally safe and well-tolerated, with serious adverse events occurring only in the sham group, indicating that iTBS may be a promising intervention for depressive symptoms in certain patients.
Dorsomedial prefrontal theta burst stimulation to treat anhedonia, avolition, and blunted affect in schizophrenia or depression - a randomized controlled trial.Bodén, R., Bengtsson, J., Thörnblom, E., et al.[2021]
Continuous theta burst stimulation (cTBS) was found to be safe and well-tolerated in patients with major depressive disorder (MDD) or bipolar depression (BD), with no significant differences in adverse events compared to sham treatment.
However, the meta-analysis of three randomized controlled trials involving 78 participants showed no significant improvement in depression scores or response rates with cTBS compared to sham, indicating that cTBS may not provide a therapeutic advantage for treating major depressive episodes.
Adjunctive continuous theta burst stimulation for major depressive disorder or bipolar depression: A meta-analysis of randomized controlled studies.Cai, DB., Qin, XD., Qin, ZJ., et al.[2023]
Continuous theta burst stimulation (cTBS) over the dorsolateral prefrontal cortex generally impairs cognitive performance in areas such as attention, planning, and decision-making, based on a review of 25 studies involving both healthy participants and those with treatment-resistant depression.
However, cTBS can also enhance cognitive performance by reducing impulsivity and the influence of distractions, indicating a complex relationship between stimulation and cognitive processes depending on the specific brain region targeted.
Assessing the Effects of Continuous Theta Burst Stimulation Over the Dorsolateral Prefrontal Cortex on Human Cognition: A Systematic Review.Ngetich, R., Zhou, J., Zhang, J., et al.[2020]

References

Dorsomedial prefrontal theta burst stimulation to treat anhedonia, avolition, and blunted affect in schizophrenia or depression - a randomized controlled trial. [2021]
Adjunctive continuous theta burst stimulation for major depressive disorder or bipolar depression: A meta-analysis of randomized controlled studies. [2023]
Assessing the Effects of Continuous Theta Burst Stimulation Over the Dorsolateral Prefrontal Cortex on Human Cognition: A Systematic Review. [2020]
Corticospinal integrity and motor impairment predict outcomes after excitatory repetitive transcranial magnetic stimulation: a preliminary study. [2016]
Neurochemical effects of theta burst stimulation as assessed by magnetic resonance spectroscopy. [2022]
Bilateral theta burst stimulation for patients with acute unipolar or bipolar depressive episodes: A systematic review of randomized controlled studies. [2023]
A Systematic Review of the Safety and Tolerability of Theta Burst Stimulation in Children and Adolescents. [2023]
Prolonged intermittent theta burst stimulation in the treatment of major depressive disorder: a case series. [2022]
The antidepressant effect of intermittent theta burst stimulation (iTBS): study protocol for a randomized double-blind sham-controlled trial. [2023]
10.United Statespubmed.ncbi.nlm.nih.gov
Intermittent theta burst stimulation (iTBS) versus 10 Hz high-frequency repetitive transcranial magnetic stimulation (rTMS) to alleviate treatment-resistant unipolar depression: A randomized controlled trial (THETA-DEP). [2022]
11.United Statespubmed.ncbi.nlm.nih.gov
Subthreshold stimulation intensity is associated with greater clinical efficacy of intermittent theta-burst stimulation priming for Major Depressive Disorder. [2021]